Latest Insider Transactions at Aclaris Therapeutics, Inc. (ACRS)
This section provides a real-time view of insider transactions for Aclaris Therapeutics, Inc. (ACRS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aclaris Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aclaris Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,934
-3.43%
|
$118,416
$24.06 P/Share
|
|
Mar 01
2021
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,175
+10.67%
|
-
|
|
Mar 01
2021
|
David N. Gordon Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,660
-5.23%
|
$135,840
$24.06 P/Share
|
|
Mar 01
2021
|
David N. Gordon Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,600
+16.0%
|
-
|
|
Feb 02
2021
|
Anand Mehra |
BUY
Exercise of conversion of derivative security
|
Direct |
14,632
+21.27%
|
$263,376
$18.34 P/Share
|
|
Feb 01
2021
|
Neal Walker INTERIM PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,316
-0.29%
|
$69,636
$21.35 P/Share
|
|
Feb 01
2021
|
Neal Walker INTERIM PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,800
+0.92%
|
-
|
|
Feb 01
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,318
-1.03%
|
$27,678
$21.35 P/Share
|
|
Feb 01
2021
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,875
+2.94%
|
-
|
|
Feb 01
2021
|
Frank Ruffo Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,308
-0.6%
|
$27,468
$21.35 P/Share
|
|
Feb 01
2021
|
Frank Ruffo Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,875
+1.76%
|
-
|
|
Dec 15
2020
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
498
-0.4%
|
$1,992
$4.59 P/Share
|
|
Dec 15
2020
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,734
+1.37%
|
-
|
|
Dec 15
2020
|
Frank Ruffo Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
370
-0.17%
|
$1,480
$4.59 P/Share
|
|
Dec 15
2020
|
Frank Ruffo Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300
+0.61%
|
-
|
|
Dec 15
2020
|
Neal Walker INTERIM PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
871
-0.08%
|
$3,484
$4.59 P/Share
|
|
Dec 15
2020
|
Neal Walker INTERIM PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,034
+0.26%
|
-
|
|
Jun 27
2019
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
699,475
-12.94%
|
$1,398,950
$2.69 P/Share
|
|
Jun 26
2019
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,704
-0.03%
|
$6,816
$4.5 P/Share
|
|
Jun 25
2019
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
51,484
-1.03%
|
$205,936
$4.51 P/Share
|
|
Jun 24
2019
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
63,240
-1.25%
|
$252,960
$4.52 P/Share
|
|
Jun 21
2019
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
339,537
-6.28%
|
$1,358,148
$4.62 P/Share
|
|
May 10
2019
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
180,565
-4.19%
|
$1,083,390
$6.05 P/Share
|
|
May 09
2019
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
434,145
-9.04%
|
$2,604,870
$6.16 P/Share
|